A citation-based method for searching scientific literature

Ricardo Gargini, Berta Segura-Collar, Pilar Sánchez-Gómez. Cancers (Basel) 2020
Times Cited: 6







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
66

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Florian Klemm, Roeltje R Maas, Robert L Bowman, Mara Kornete, Klara Soukup, Sina Nassiri, Jean-Philippe Brouland, Christine A Iacobuzio-Donahue, Cameron Brennan, Viviane Tabar,[...]. Cell 2020
137
50

Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.
Ekaterina Friebel, Konstantina Kapolou, Susanne Unger, Nicolás Gonzalo Núñez, Sebastian Utz, Elisabeth Jane Rushing, Luca Regli, Michael Weller, Melanie Greter, Sonia Tugues,[...]. Cell 2020
108
33

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Joseph A Flores-Toro, Defang Luo, Adithya Gopinath, Matthew R Sarkisian, James J Campbell, Israel F Charo, Rajinder Singh, Thomas J Schall, Meenal Datta, Rakesh K Jain,[...]. Proc Natl Acad Sci U S A 2020
71
33

The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas.
Ricardo Gargini, Berta Segura-Collar, Beatriz Herránz, Vega García-Escudero, Andrés Romero-Bravo, Felipe J Núñez, Daniel García-Pérez, Jacqueline Gutiérrez-Guamán, Angel Ayuso-Sacido, Joan Seoane,[...]. Sci Transl Med 2020
16
33

The role of microglia and macrophages in glioma maintenance and progression.
Dolores Hambardzumyan, David H Gutmann, Helmut Kettenmann. Nat Neurosci 2016
623
33

Immune microenvironment of gliomas.
Anna Gieryng, Dominika Pszczolkowska, Kacper A Walentynowicz, Wenson D Rajan, Bozena Kaminska. Lab Invest 2017
163
33

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
33

Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Wenchao Zhou, Cong Chen, Yu Shi, Qiulian Wu, Ryan C Gimple, Xiaoguang Fang, Zhi Huang, Kui Zhai, Susan Q Ke, Yi-Fang Ping,[...]. Cell Stem Cell 2017
87
33

Astrocyte-endothelial interactions at the blood-brain barrier.
N Joan Abbott, Lars Rönnbäck, Elisabeth Hansson. Nat Rev Neurosci 2006
33

Development, maintenance and disruption of the blood-brain barrier.
Birgit Obermeier, Richard Daneman, Richard M Ransohoff. Nat Med 2013
33

Establishment and Dysfunction of the Blood-Brain Barrier.
Zhen Zhao, Amy R Nelson, Christer Betsholtz, Berislav V Zlokovic. Cell 2015
653
33

Pericytes are required for blood-brain barrier integrity during embryogenesis.
Richard Daneman, Lu Zhou, Amanuel A Kebede, Ben A Barres. Nature 2010
33

The blood-brain barrier.
Richard Daneman, Alexandre Prat. Cold Spring Harb Perspect Biol 2015
841
33

Mfsd2a is critical for the formation and function of the blood-brain barrier.
Ayal Ben-Zvi, Baptiste Lacoste, Esther Kur, Benjamin J Andreone, Yoav Mayshar, Han Yan, Chenghua Gu. Nature 2014
440
33

The Microenvironmental Landscape of Brain Tumors.
Daniela F Quail, Johanna A Joyce. Cancer Cell 2017
543
33

Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy.
Zhihao Yang, Erbao Bian, Yadi Xu, Xinghu Ji, Feng Tang, Chunchun Ma, Hongliang Wang, Bing Zhao. Onco Targets Ther 2020
13
33

Brain immunology and immunotherapy in brain tumours.
John H Sampson, Michael D Gunn, Peter E Fecci, David M Ashley. Nat Rev Cancer 2020
111
33

Primary brain tumours in adults.
Sarah Lapointe, Arie Perry, Nicholas A Butowski. Lancet 2018
351
33

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Yang Xu, Renpeng Li, Xiaoxia Li, Naijun Dong, Di Wu, Lin Hou, Kan Yin, Chunhua Zhao. Front Oncol 2020
9
33

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Tom B Davidson, Anthony C Wang, Benjamin M Ellingson, Julie A Rytlewski, Catherine M Sanders,[...]. Nat Med 2019
395
16

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.
Mirco Friedrich, Lukas Bunse, Wolfgang Wick, Michael Platten. Curr Opin Oncol 2018
7
16

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
Andrew S Venteicher, Itay Tirosh, Christine Hebert, Keren Yizhak, Cyril Neftel, Mariella G Filbin, Volker Hovestadt, Leah E Escalante, McKenzie L Shaw, Christopher Rodman,[...]. Science 2017
339
16


Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours.
Adama Sidibe, Patricia Ropraz, Stéphane Jemelin, Yalin Emre, Marine Poittevin, Marc Pocard, Paul F Bradfield, Beat A Imhof. Nat Commun 2018
42
16

Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
Ioannis Kaffes, Frank Szulzewsky, Zhihong Chen, Cameron J Herting, Ben Gabanic, José E Velázquez Vega, Jennifer Shelton, Jeffrey M Switchenko, James L Ross, Leon F McSwain,[...]. Oncoimmunology 2019
35
16

Glioblastoma-activated pericytes support tumor growth via immunosuppression.
Isadora F G Sena, Ana E Paiva, Pedro H D M Prazeres, Patrick O Azevedo, Luiza Lousado, Sujit K Bhutia, Alla B Salmina, Akiva Mintz, Alexander Birbrair. Cancer Med 2018
36
16

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.
Lin Tian, Amit Goldstein, Hai Wang, Hin Ching Lo, Ik Sun Kim, Thomas Welte, Kuanwei Sheng, Lacey E Dobrolecki, Xiaomei Zhang, Nagireddy Putluri,[...]. Nature 2017
309
16

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, Clemens Mayer, Mirjana Efremova, Dietmar Rieder, Hubert Hackl, Zlatko Trajanoski. Cell Rep 2017
822
16

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, Bart Neyns, Kiavash Movahedi, Jo A Van Ginderachter. Elife 2020
54
16

Targeting VEGF/VEGFR to Modulate Antitumor Immunity.
Ju Yang, Jing Yan, Baorui Liu. Front Immunol 2018
183
16

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.
Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, Orsolya Rajky, Gerda Ricken, Adelheid Wöhrer, Karin Dieckmann, Martin Filipits, Anita Brandstetter, Michael Weller,[...]. Neuro Oncol 2015
325
16

Corticosteroids compromise survival in glioblastoma.
Kenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, Amira Hosni-Ahmed, Siobhan S Pattwell, Shannon Donnola, Charles Dai, Tatsuya Ozawa, Maria Chang, Timothy A Chan,[...]. Brain 2016
172
16

Recurrent glioma clinical trial, CheckMate-143: the game is not over yet.
Anna C Filley, Mario Henriquez, Mahua Dey. Oncotarget 2017
177
16

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.
Lukas Bunse, Stefan Pusch, Theresa Bunse, Felix Sahm, Khwab Sanghvi, Mirco Friedrich, Dalia Alansary, Jana K Sonner, Edward Green, Katrin Deumelandt,[...]. Nat Med 2018
137
16

Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma.
Nicole Simonavicius, David Robertson, Dorine A Bax, Chris Jones, Ivo J Huijbers, Clare M Isacke. Mod Pathol 2008
73
16

PD-L1 expression and prognostic impact in glioblastoma.
Edjah K Nduom, Jun Wei, Nasser K Yaghi, Neal Huang, Ling-Yuan Kong, Konrad Gabrusiewicz, Xiaoyang Ling, Shouhao Zhou, Cristina Ivan, Jie Qing Chen,[...]. Neuro Oncol 2016
291
16

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Gary Kohanbash, Diego A Carrera, Shruti Shrivastav, Brian J Ahn, Naznin Jahan, Tali Mazor, Zinal S Chheda, Kira M Downey, Payal B Watchmaker, Casey Beppler,[...]. J Clin Invest 2017
167
16

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.
Sevin Turcan, Daniel Rohle, Anuj Goenka, Logan A Walsh, Fang Fang, Emrullah Yilmaz, Carl Campos, Armida W M Fabius, Chao Lu, Patrick S Ward,[...]. Nature 2012
16

Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
Koichi Ichimura, Yoshitaka Narita, Cynthia E Hawkins. Acta Neuropathol 2015
31
16

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
Diana Cantero, Ángel Rodríguez de Lope, Raquel Moreno de la Presa, Juan M Sepúlveda, José M Borrás, Javier S Castresana, Nicky D'Haene, Juan F García, Isabelle Salmon, Manuela Mollejo,[...]. J Neuropathol Exp Neurol 2018
19
16

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.
Albert Lai, Samir Kharbanda, Whitney B Pope, Anh Tran, Orestes E Solis, Franklin Peale, William F Forrest, Kanan Pujara, Jose A Carrillo, Ajay Pandita,[...]. J Clin Oncol 2011
298
16

Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.
Andrea E Calvert, Alexandra Chalastanis, Yongfei Wu, Lisa A Hurley, Fotini M Kouri, Yingtao Bi, Maureen Kachman, Jasmine L May, Elizabeth Bartom, Youjia Hua,[...]. Cell Rep 2017
79
16

Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Marine Jeanmougin, Annette B Håvik, Lina Cekaite, Petter Brandal, Anita Sveen, Torstein R Meling, Trude H Ågesen, David Scheie, Sverre Heim, Ragnhild A Lothe,[...]. Mol Oncol 2020
9
16

Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Suvi Luoto, Ismaïl Hermelo, Elisa M Vuorinen, Paavo Hannus, Juha Kesseli, Matti Nykter, Kirsi J Granberg. Cancer Res 2018
27
16

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Qianghu Wang, Baoli Hu, Xin Hu, Hoon Kim, Massimo Squatrito, Lisa Scarpace, Ana C deCarvalho, Sali Lyu, Pengping Li, Yan Li,[...]. Cancer Cell 2017
566
16

Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
Joseph P Antonios, Horacio Soto, Richard G Everson, Diana Moughon, Joey R Orpilla, Namjo P Shin, Shaina Sedighim, Janet Treger, Sylvia Odesa, Alexander Tucker,[...]. Neuro Oncol 2017
81
16

Immune landscapes associated with different glioblastoma molecular subtypes.
Maria Martinez-Lage, Timothy M Lynch, Yingtao Bi, Carolina Cocito, Gregory P Way, Sharmistha Pal, Josephine Haller, Rachel E Yan, Amy Ziober, Aivi Nguyen,[...]. Acta Neuropathol Commun 2019
42
16

Mutant IDH1 regulates the tumor-associated immune system in gliomas.
Nduka M Amankulor, Youngmi Kim, Sonali Arora, Julia Kargl, Frank Szulzewsky, Mark Hanke, Daciana H Margineantu, Aparna Rao, Hamid Bolouri, Jeff Delrow,[...]. Genes Dev 2017
180
16

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
Rashid Deane, Itender Singh, Abhay P Sagare, Robert D Bell, Nathan T Ross, Barbra LaRue, Rachal Love, Sheldon Perry, Nicole Paquette, Richard J Deane,[...]. J Clin Invest 2012
360
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.